glp-1 surgery guidance news Are Serious Anesthesia Risks of Semaglutide and Other Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia GLP-1 Medications for Weight Loss:

Designed as an easy daily protein shake to help maintain consistent protein intake while supporting an active lifestyle

Recently published studies of islet cell function reveal unexpected features of glucagon-like peptide-1 (GLP-1) receptor-mediated signal transduction...

A compact and user-friendly pre-filled pen device designed for subcutaneous medication delivery.

We've known for years that metabolic health and emotional regulation are intertwined

Experts explain why hunger, food noise and other health changes return after stopping weight loss drugs and how to hold onto your progress.

95% CI 0.750.98, p=0.03), Dulaglutide (RR 0.82, 95% CI 0.700.96, p=0.02), Albiglutide (RR 0.93,95% CI 0.791.10, p=0.40), Exenatide (RR 0.93, 95% CI 0.741.18, p=0.55), Lixisenatide (RR 0.83, 95% CI 0.621.12, p=0.22), and Efpeglenatide (RR 0.76, 95% CI 0.461.24, p=0.27)